close

New Drug, ANS-858, Aims To Reduce Alcohol And Drug Cravings

Jessica Sherer August 24, 2026

FDA clearance allows clinical trials to begin for ANS-858, a new drug targeting cravings associated with alcohol and substance use disorders.

Kristen Fuller, MD August 19, 2026

The VA is launching a national trial to study psilocybin as a potential treatment for treatment-resistant depression in veterans.

Jessica Sherer January 15, 2026

The Trump administration reversed its decision to cut $2 billion in mental health and addiction grants after a wave of bipartisan backlash.

Kristen Fuller, MD December 14, 2025

The SUPPORT for Patients and Communities Reauthorization Act of 2025 authorizes pharmacists to prescribe buprenorphine for opioid treatment.

Kristen Fuller, MD October 3, 2025

Older adults are receiving substandard care for opioid use disorders, with more than 60% of Medicare enrollees getting subpar OUD treatment.

Hayley Hudson May 12, 2025

The Trump administration's consolidation of several programs, including SAMHSA, under the new AHA has many addiction experts worried.

Jessica Sherer April 7, 2025

Art Kleinschmidt was appointed principal deputy assistant secretary of the Substance Abuse and Mental Health Services Administration (SAMHSA).

Kristen Fuller, MD July 1, 2024

Both candidates did not have an answer on how to help Americans with addiction. This is a major concern for the U.S.

Jessica Sherer October 3, 2023

Studies show that insomnia drug Suvorexant may help treat Opioid withdrawal symptoms and relapse by improving sleep quality.